Ephraim Fields revealed that they own a 4.9% stake in Arotech Corp. (NASDAQ:ARTX) in a Form 13D/A disclosure that was filed with the SEC on Wednesday, October 12th. The investor owns 1,304,355 shares of the stock worth approximately $4,278,284. The disclosure is available through the SEC website at this link.
Other hedge funds also recently made changes to their positions in the company. Cannell Capital LLC acquired a new stake in shares of Arotech Corp. during the second quarter valued at $938,000. Spark Investment Management LLC increased its stake in shares of Arotech Corp. by 510.8% in the second quarter. Spark Investment Management LLC now owns 158,800 shares of the company’s stock valued at $446,000 after buying an additional 132,800 shares during the last quarter. TFS Capital LLC acquired a new stake in shares of Arotech Corp. during the second quarter valued at $138,000. Vanguard Group Inc. increased its stake in shares of Arotech Corp. by 24.0% in the second quarter. Vanguard Group Inc. now owns 942,064 shares of the company’s stock valued at $2,647,000 after buying an additional 182,544 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Arotech Corp. by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 472,215 shares of the company’s stock valued at $1,327,000 after buying an additional 11,609 shares during the last quarter. 16.00% of the stock is currently owned by institutional investors and hedge funds.
Arotech Corp. (NASDAQ:ARTX) traded down 3.35% during mid-day trading on Wednesday, hitting $3.17. The stock had a trading volume of 219,662 shares. The firm’s market cap is $80.46 million. The stock has a 50 day moving average of $2.98 and a 200-day moving average of $2.95. Arotech Corp. has a 1-year low of $1.32 and a 1-year high of $4.13.
Arotech Corp. (NASDAQ:ARTX) last announced its quarterly earnings data on Monday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. The business had revenue of $21.80 million for the quarter, compared to analysts’ expectations of $21.60 million. Arotech Corp. had a negative net margin of 1.70% and a positive return on equity of 2.25%. Analysts predict that Arotech Corp. will post ($0.09) EPS for the current fiscal year.
Several analysts have weighed in on the company. Zacks Investment Research raised Arotech Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday. B. Riley reaffirmed a “buy” rating and set a $4.50 target price on shares of Arotech Corp. in a research note on Sunday, August 14th. Finally, TheStreet raised Arotech Corp. from a “sell” rating to a “hold” rating in a research note on Thursday, July 7th.
In other news, Chairman Jon B. Kutler acquired 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 22nd. The shares were acquired at an average cost of $2.60 per share, with a total value of $26,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 17.30% of the stock is currently owned by corporate insiders.
About Arotech Corp.
Arotech Corporation is a defense and security products and services company, engaged in providing interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military, commercial and medical markets. The Company operates through two segments: Training and Simulation Division, and Power Systems Division.
Want to see what other hedge funds are holding ARTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arotech Corp. (NASDAQ:ARTX).
Receive News & Ratings for Arotech Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arotech Corp. and related companies with MarketBeat.com's FREE daily email newsletter.